Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea

University of Cincinnati

Status and phase: Completed; Phase 4

Conditions: Obstructive Sleep Apnea

Treatments: Device: Pillar Palatal Implants

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00307957

05-08-14-1

Details and patient eligibility

About

The Pillar palatal implant procedure is a minimally invasive and commercially available treatment for mild to moderate obstructive sleep apnea (OSA) in the United States and Europe. The implants are placed into the soft area in the roof of the mouth providing support to the soft palate. This research is being done to compare daytime sleepiness and sleep related quality of life after palatal implants.

Full description

Patients will be enrolled into the study based on sleep study results, a physical exam and inclusion/exclusion criteria. Once enrolled, patients are randomized into either the Pillar palatal implant group or a placebo/sham group.

In both cases, patients come into the office for placement of the implants. This is an outpatient procedure. Patients are followed at one week, one month and 3 months. At each follow-up visit, patients will undergo a physical exam and complete questionnaires related to sleep and quality of life. Patients will also undergo reaction time testing on hand-held device similar to a pocket video game. At the three month visit, patients will return to the sleep lab for another sleep study.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18 years or older
• Body Mass Index equal to 32 or less
• Apnea-Hypopnea Index greater than/equal to 10 and less than/equal to 30
• Symptoms of daytime sleepiness

Exclusion criteria

• Septal deviation or nasal obstruction
• Nasal polyps
• Severe seasonal allergies
• Soft palate length insufficient to accommodate implants
• Fujita Modified Mallampati Class 3
• Large tonsils
• Lingual tonsil hypertrophy
• Hypopharyngeal obstruction
• Previous pharyngeal surgery
• Previous upper respiratory tract cancer or radiation therapy
• Active respiratory tract infection
• Dysphagia or speech disorder
• Neurologic disorder
• Unstable psychiatric disorder
• Pregnant or breastfeeding
• History of falling asleep driving or MVA due to sleepiness
• Currently on CPAP therapy or other device for OSA
• Other sleep disorders

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind